ArticleInternational journal of nanomedicine2025

ROS-Responsive Nanosystem Targeted Co-Delivery YC-1 and Regorafenib to Alleviate Hypoxia Enhancing Hepatocellular Carcinoma Therapy.

Liming Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.